mifepristone has been researched along with Acute Lymphoid Leukemia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harada, H; Heidari, N; Hicks, MA; Marking, CB; Miller, AV | 1 |
| Miller, AL; Thompson, EB; Webb, MS | 1 |
| Johnson, BH; Saeed, MF; Thompson, EB; Thulasi, R | 1 |
| Johnson, BH; Medh, RD; Saeed, MF; Thompson, EB | 1 |
4 other study(ies) available for mifepristone and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
Glucocorticoid-mediated BIM induction and apoptosis are regulated by Runx2 and c-Jun in leukemia cells.
Topics: Apoptosis; Apoptosis Regulatory Proteins; Bcl-2-Like Protein 11; Binding Sites; Cell Line, Tumor; Core Binding Factor Alpha 1 Subunit; Dexamethasone; Glucocorticoids; HEK293 Cells; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; Jurkat Cells; Membrane Proteins; Mifepristone; p38 Mitogen-Activated Protein Kinases; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Promoter Regions, Genetic; Protein Kinase Inhibitors; Proto-Oncogene Proteins; Pyridines; Receptors, Glucocorticoid; RNA Interference; RNA, Small Interfering; Signal Transduction; Transcription Factor AP-1 | 2012 |
Comparison of two structurally diverse glucocorticoid receptor agonists: cortivazol selectively regulates a distinct set of genes separate from dexamethasone in CEM cells.
Topics: Apoptosis; Cell Line; Dexamethasone; Gene Expression Regulation, Neoplastic; Glucocorticoids; Humans; Mifepristone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pregnatrienes; Receptors, Glucocorticoid | 2007 |
Glucocorticoid antagonist RU 486 reverses agonist-induced apoptosis and c-myc repression in human leukemic CEM-C7 cells.
Topics: Apoptosis; Cyclic AMP-Dependent Protein Kinases; Dexamethasone; Down-Regulation; Genes, myc; Humans; Mifepristone; Models, Biological; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Receptors, Glucocorticoid; RNA, Messenger; RNA, Neoplasm; Tumor Cells, Cultured | 1995 |
Resistance of human leukemic CEM-C1 cells is overcome by synergism between glucocorticoid and protein kinase A pathways: correlation with c-Myc suppression.
Topics: Apoptosis; Cell Survival; Colforsin; Cyclic AMP-Dependent Protein Kinases; Dexamethasone; Down-Regulation; Drug Resistance, Neoplasm; Drug Synergism; Enzyme Activation; Glucocorticoids; Humans; Mifepristone; Neoplasm Proteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogene Proteins c-myc; Receptors, Glucocorticoid; Signal Transduction; Time Factors; Transcriptional Activation; Tumor Cells, Cultured | 1998 |